
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 45 results:
Author Title Type [ Year
Filters: First Letter Of Title is G [Clear All Filters]
,
“Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study”, Int J Chron Obstruct Pulmon Dis, vol. 15, pp. 2355-2366, 2020.
, “Generating high-fidelity synthetic patient data for assessing machine learning healthcare software”, NPJ Digit Med, 2020.
, “Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis”, BMJ Open Diabetes Res Care, vol. 8, 2020.
, “Glucocorticoid use is associated with an increased risk of hypertension”, Rheumatology (Oxford), 2020.
, , , “The Generalized Data Model for clinical research”, BMC Med Inform Decis Mak, vol. 19, p. 117, 2019.
, “Genome-wide association study of statin-induced myopathy in patients recruited using the UK clinical practice research datalink”, Clin Pharmacol Ther, 2019.
, “Glucose, cholesterol and blood pressure in type II diabetes: A longitudinal observational study comparing patients with and without severe mental illness”, J Psychiatr Ment Health Nurs, 2019.
, “Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus”, Diabetes Res Clin Pract, p. 107791, 2019.
, “Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study”, BMJ Open, vol. 9, p. e031550, 2019.
, “Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study”, Br J Clin Pharmacol, vol. 84, pp. 2142-2151, 2018.
, “Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK”, Cancer Epidemiol, vol. 54, pp. 104-111, 2018.
, “Generalizing Randomized Clinical Trial Results: Implementation and Challenges Related to Missing Data in the Target Population”, Am J Epidemiol, vol. 187, pp. 817-827, 2018.
, “Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy”, Diabetes Care, vol. 41, pp. 2330-2338, 2018.
, “Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study”, Diabetes Ther, vol. 9, pp. 269-283, 2018.
, “Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study”, Diabetes Care, vol. 41, pp. 2127-2135, 2018.
, “GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)”, Pharmacoepidemiol Drug Saf, 2018.
, “Gender differences in COPD exacerbations: Analysis from the CPRD database”, Thorax, vol. 72, p. A186, 2017.
, “Gender inequality in acute gastro-enteritis rates in England.”, Value in Health, vol. 20, p. A781, 2017.
, “Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study”, Osteoporos Int, vol. 28, pp. 169-178, 2017.
, “Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink”, Rheumatology (Oxford), vol. 56, pp. 753-762, 2017.
, “Gout and subsequent erectile dysfunction: a population-based cohort study from England”, Arthritis Res Ther, vol. 19, p. 123, 2017.
, “Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink”, Bmj, vol. 355, p. i5340, 2016.
, “Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study”, Diabetes Ther, vol. 7, pp. 695-711, 2016.
, “Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study”, PLoS Med, vol. 12, p. e1001854, 2015.
, “Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study”, Diabetologia, vol. 58, pp. 505-18, 2015.
, “Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer”, Diabetes Obes Metab, vol. 17, pp. 350-62, 2015.
, ,
“Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data”, Diabetologia, vol. 55, pp. 654-65, 2012.
, “Genital warts and cost of care in England”, Sex Transm Infect, vol. 87, pp. 464-8, 2011.
, “Gynaecological symptoms reported by young women: examining the potential for earlier diagnosis of cervical cancer”, Fam Pract, vol. 28, pp. 592-8, 2011.
, “Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look”, Br J Clin Pharmacol, vol. 66, pp. 76-81, 2008.
, “Gout and risk of Parkinson disease: a prospective study”, Neurology, vol. 69, pp. 1696-700, 2007.
, “Glucocorticoid use, other associated factors, and the risk of tuberculosis”, Arthritis Rheum, vol. 55, pp. 19-26, 2006.
, “Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice”, Chest, vol. 128, pp. 85-93, 2005.
, “General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction”, Heart, vol. 91, pp. 465-71, 2005.
, “Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes”, Diabetes Care, vol. 28, pp. 995-1000, 2005.
, “Gout epidemiology: results from the UK General Practice Research Database, 1990-1999”, Ann Rheum Dis, vol. 64, pp. 267-72, 2005.
, “The general fertility rate in women with psychotic disorders”, Am J Psychiatry, vol. 159, pp. 991-7, 2002.
, “Geriatric drug therapy and healthcare utilization in the United kingdom”, Ann Pharmacother, vol. 36, pp. 797-803, 2002.
, “Gender and drug treatment as determinants of mortality in a cohort of heart failure patients”, Eur J Epidemiol, vol. 17, pp. 329-35, 2001.
, “Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk?”, Epidemiology, vol. 8, pp. 571-4, 1997.
, “The General Practice Research Database: quality of morbidity data”, Popul Trends, pp. 36-40, 1997.
,